AU Patent

AU2008216083A1 — Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders

Assigned to Jazz Pharmaceuticals Therapeutics Inc · Expires 2008-08-21 · 18y expired

What this patent protects

Patent listed against Cytarabine.

Drugs covered by this patent

Cytarabine (Cytarabine) · Nippon Shinyaku Co., Ltd.

Patent Metadata

Patent number: AU2008216083A1
Jurisdiction: AU
Classification: —
Expires: 2008-08-21
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.